ConductScience.org, home

Paper11547741

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Macdonald JS and 10 others. N Engl J Med, 2001. Cited by 2,705 papers, by iCite.

Cite this record

ConductScience Library. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. Papers, record 11547741. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11547741

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
PubMed
Journal
N Engl J Med
PubMed
Year
2001
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
2,705
iCite
Relative citation ratio, by iCite
67.1
iCite
Revised in PubMed
2024-01-03
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Macdonald JSJ S
2Smalley SRS R
3Benedetti JJ
4Hundahl SAS A
5Estes NCN C
6Stemmermann GNG N
7Haller DGD G
8Ajani JAJ A
9Gunderson LLL L
10Jessup JMJ M
11Martenson JAJ A

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Antimetabolites, AntineoplasticMajor topic
Esophagogastric JunctionMajor topic
FluorouracilMajor topic
Stomach NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
Combined Modality Therapy
Disease-Free Survival
Female
Gastrectomy
Humans
Leucovorin
Lymph Node Excision
Male
Middle Aged
Radiation Dosage
Survival Rate

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA32102NCI NIH HHSUnited StatesR10CA032102PubMed and NIHNIH RePORTER
CA35176NCI NIH HHSUnited StatesU10CA035176PubMed and NIHNIH RePORTER
CA38926NCI NIH HHSUnited StatesU10CA038926PubMed and NIHNIH RePORTER
U10CA032102NIHNIH RePORTER

Download CSV of grants

Trials7

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT02078362ADCC Against Gastric Cancer CellsBackgroundClinicalTrials.gov
NCT02640898Docetaxel-based Chemoradiotherapy Plus Periradiation Chemotherapy Compared With INT 0116 Adjuvant Arm in Gastric CancerBackgroundClinicalTrials.gov
NCT03515941Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric CancersBackgroundClinicalTrials.gov
NCT03601988Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric CancerBackgroundClinicalTrials.gov
NCT03680261Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. ChemoradiotherapyBackgroundClinicalTrials.gov
NCT04808466Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal ChemotherapyBackgroundClinicalTrials.gov
NCT06784765Preventive Use of PIPAC in Locally Advanced Gastric Cancer.ResultsClinicalTrials.gov

Download CSV of trials

Comments and corrections6

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in11796861Adjuvant chemoradiotherapy for gastric cancer.https://conductscience.org/library/papers/11796861PubMed
Comment in11797725Adjuvant chemoradiotherapy for gastric cancer.https://conductscience.org/library/papers/11797725PubMed
Comment in11797726Adjuvant chemoradiotherapy for gastric cancer.https://conductscience.org/library/papers/11797726PubMed
Comment in12010873Does chemoradiotherapy after intended curative surgery increase survival of gastric cancer patients?https://conductscience.org/library/papers/12010873PubMed
Comment in15218575Chemotherapy for pancreatic cancer.https://conductscience.org/library/papers/15218575PubMed
Comment in17014037Treatment of gastric cancer.https://conductscience.org/library/papers/17014037PubMed

Download CSV of comments and corrections

Cited by1,282

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,705 citations.

PMIDTitleJournalYearIn PapersSource
42978552Comparative outcomes of adjuvant treatment approaches in resected stage I-III gastric cancer.Front Oncol2026https://conductscience.org/library/papers/42978552PubMed
42730213Chemoradiotherapy Is Associated With Improved Overall Survival in Intestinal-Type Gastric Cancer: A Retrospective Analysis.World J Oncol2026https://conductscience.org/library/papers/42730213PubMed
42719170Case Report: Two cases of pathologic complete response after upfront chemoimmunotherapy for initially unresectable gastric cancer.Front Oncol2026https://conductscience.org/library/papers/42719170PubMed
42512265Perioperative Nivolumab and Ipilimumab with Chemotherapy and Chemoradiation for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma: A Phase 1/2 Non-Randomized Clinical Trial.Cancers (Basel)2026https://conductscience.org/library/papers/42512265PubMed
42466102Impact of postoperative chemotherapy in patients resected for esophagogastric adenocarcinoma with major pathological response after preoperative chemotherapy: a study from the FREGAT database.Ther Adv Med Oncol2026https://conductscience.org/library/papers/42466102PubMed
42459646Decoding the PTM code of cGAS-STING in gastric cancer: from innate DNA sensing to precision combination therapy.Front Immunol2026https://conductscience.org/library/papers/42459646PubMed
42387114Multi-modal Prehabilitation and Outcomes after Gastroesophageal Cancer Surgery: A Cohort Study of Pulmonary Complications and Resilience to Major Postoperative Events.Ann Surg Oncol2026https://conductscience.org/library/papers/42387114PubMed
42352878The p53 Isoforms as Potential Biomarkers in Different Cancer Entities.Int J Mol Sci2026https://conductscience.org/library/papers/42352878PubMed
42311712Emerging Role of Immunotherapy in Neoadjuvant, Adjuvant, and Perioperative Management of Gastric Cancer.Cureus2026https://conductscience.org/library/papers/42311712PubMed
42295761Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer: A Randomized Clinical Trial.JAMA Netw Open2026https://conductscience.org/library/papers/42295761PubMed
42141340Biomarker-Driven Management of Nonmetastatic GEJ Adenocarcinoma.Ann Surg Oncol2026https://conductscience.org/library/papers/42141340PubMed
42141214Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons.Nat Rev Clin Oncol2026https://conductscience.org/library/papers/42141214PubMed
42116136
Adjuvant chemotherapy and lymph node examination interact to shape survival in older adults (≥ 75 years) with resected gastric cancer: a SEER-based propensity score-matched and competing-risk analysis.
World J Surg Oncol2026https://conductscience.org/library/papers/42116136PubMed
41999560Survival Impact of Adjuvant Chemotherapy on Stage IB Gastric Cancer Patients After Radical Surgery.J Gastrointest Cancer2026https://conductscience.org/library/papers/41999560PubMed
41976296Robotic Gastrectomy and Delivery of Adjuvant Systemic Therapy in Locally Advanced Gastric Adenocarcinoma: An NCDB Propensity Score-Matched Analysis.Cancers (Basel)2026https://conductscience.org/library/papers/41976296PubMed
41949664Machine learning nomograms for gastric cancer: addressing data limitations in SEER-based models.Langenbecks Arch Surg2026https://conductscience.org/library/papers/41949664PubMed
41938584A prognostic nomogram integrating preoperative IBI and MAR with clinicopathological factors for gastric cancer patients after radical gastrectomy.Front Surg2026https://conductscience.org/library/papers/41938584PubMed
41859180Perioperative chemotherapy (FLOT 4 + 4) versus total neoadjuvant therapy (TNT; FLOT ×8) for resectable gastric cancer: A systematic review and exploratory meta-analysis.Surg Open Sci2026https://conductscience.org/library/papers/41859180PubMed
41774292Clinicopathologic features and prognostic impact of late recurrence after gastrectomy for gastric cancer.Gastric Cancer2026https://conductscience.org/library/papers/41774292PubMed
41711159Cryptotanshinone alleviates DSS-induced colitis in mouse by regulating the balance of Treg/Th17 cells and M1 macrophage activation.Eur J Histochem2026https://conductscience.org/library/papers/41711159PubMed

See all 1,282 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11547741

GET https://conductscience.org/api/papers/v1/11547741/cited_by?page=2